Novo Nordisk A/S (NYSE:NVO)

48.72
Delayed Data
As of May 18
 -0.27 / -0.55%
Today’s Change
40.16
Today|||52-Week Range
58.37
-9.22%
Year-to-Date

Stock Price Forecast

The 29 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 56.18, with a high estimate of 69.57 and a low estimate of 31.83. The median estimate represents a +15.31% increase from the last price of 48.72.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.66
Sales
$4.4B
Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.94%
 
 
 
 
 
 
Growthannually 3.34%
 
 
 
 
 
 

Sales

Growthquarterly 2.23%
 
 
 
 
 
 
Growthannually -1.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.